1.95

1.95 (0.33%)

As of Feb 20, 2024

GERON CORP [GERN]

Source: 

Company Overview

Geron Corp is a late-stage biopharmaceutical company pursuing therapies with the potential to extend and enrich the lives of patients living with hematologic malignancies. Our investigational first-in-class telomerase inhibitor, imetelstat, harnesses Nobel Prize winning science in a treatment that may alter the underlying course of these diseases.

CountryUS
Headquartersfoster citycalifornia
Phone Number(650) 473-7700
Industrypharmaceutical preparations
CEOJohn A. Scarlett
Websitegeron.com